0001367644-22-000048.txt : 20220303
0001367644-22-000048.hdr.sgml : 20220303
20220303182807
ACCESSION NUMBER: 0001367644-22-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fox Jennifer Lynne
CENTRAL INDEX KEY: 0001914879
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 22710984
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DRIVE
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_164635006141702.xml
FORM 4
X0306
4
2022-03-01
0
0001367644
Emergent BioSolutions Inc.
EBS
0001914879
Fox Jennifer Lynne
400 PROFESSIONAL DRIVE
SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
EVP, Ext Aff, GC, Corp Sec
Common Stock
2022-03-01
4
A
0
7583
0
A
14833
D
Common Stock
2022-03-01
4
A
0
17794
0
A
32627
D
Employee Stock Options (Right to Buy)
41.38
2022-03-01
4
A
0
26584
41.38
A
2029-02-28
Common Stock
26584.0
26584
D
Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.
Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (8,713 shares) or on the day prior to the second anniversary date of the grant (9,063 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
/s/ S. Scott Lieberman Attorney-In-Fact
2022-03-03